The reason why adropin exerts multiple effects in all three vascular cells that participate in the pathogenesis of atherosclerosis could be explained by the possible presence of adropin’s own receptors, other than GPR19, in these cells. This evidence concerns the gene GPR19 and atherosclerosis.